90 studies found for: Open Studies | "Urinary Tract Infections"
Corticosteroids for Children With Febrile Urinary Tract Infections
Febrile Urinary Tract Infection Randomized Short Treatment Trial
Seven vs. 14 Days Treatment for Male Urinary Tract Infection
Symptomatic Therapy of Uncomplicated Lower Urinary Tract Infections in the Ambulatory Setting.
The SCOUT Study: Short Course Therapy for Urinary Tract Infections in Children
|6||Not yet recruiting||
Intravesical Instillation of Hyaluronic Acid to Decrease Incidence of Urinary Tract Infection
The Efficacy of Solifenacin Succinate as Adjuvant Therapy for Urinary Tract Infection in Females
|8||Not yet recruiting||
L-methionine, Hibiscus Sabdariffa and Boswellia Leaf Extract to Prevent Postoperative Urinary Tract Infection.
Study Comparing Nitrofurantoin to Fosfomycin for Acute Urinary Tract Infection in Women
Safety and Efficacy of a Weekly Oral Cyclic Antibiotic Programme in the Prevention of Urinary Tract Infection on Neurological Bladder
An Observational Study of Ertapenem in Outpatient Parenteral Antibiotic Therapy (OPAT) for Complicated Urinary Tract Infections.
Treatment of Recurrent Urinary Tract Infection (RUTI) by Traditional Chinese Medicine
Clinical Significance and Optimal Treatment of Community-onset Urinary Tract Infections Caused by Extended-spectrum β-lactamase and/or AmpC β-lactamase Producing Enterobacteriaceae
Clinical Value of Homeopathic Prophylaxis of Recurrent Urinary Tract Infections in Persons With Spinal Cord Injury
Efficacy Study of Acriflavine Hydrochloride + Methenamine + Methylthioninium Chloride vs Placebo for the Rapid Relief of Symptoms Urinary Tract Infection
|16||Not yet recruiting||
Cranberry on Urinary Tract Infections
Efficacy of Fosfomycin-Trometamol in Urinary Tract Infection Prophylaxis After Kidney Transplantation
Treatment of Extended Spectrum Betalactamase Producing Bacteria Causing Urinary Tract Infections in General Practice
Cranberry-lingonberry Juice Started During Acute Infection in Prevention of Urinary Tract Infections in Children
Study of the Safety, Tolerability, and Efficacy of MK-7655 + Imipenem/Cilastatin Versus Imipenem/Cilastatin Alone for the Treatment of Complicated Urinary Tract Infection (cUTI) (MK-7655-003)
† Indicates status has not been verified in more than two years